Hypofractionated radiotherapy regimens after organ-sparing surgery for stages I–IIa breast cancer
- Authors: Efimkina Y.V.1, Gladilina I.A.1, Nechushkin M.I.1, Kozlov O.V.1
-
Affiliations:
- Department of Radiosurgery, N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, Moscow
- Issue: No 3 (2011)
- Pages: 45-53
- Section: MAMMOLOGY. TREATMENT
- Published: 14.08.2011
- URL: https://ojrs.abvpress.ru/ojrs/article/view/176
- DOI: https://doi.org/10.17650/1994-4098-2011-0-3-45-53
- ID: 176
Cite item
Full Text
Abstract
The results of basic clinical randomized trials of hypofractionated (HF) radiotherapy (R T) regimens used after organ-sparing su rgery for Stages I-IIa breast cancer (BC) were analyzed. The HF adjuvant RT regimens were shown to be safe and an alternative to the standard RT in patients with BC after organ-saving operations.
Keywords
About the authors
Yu. V. Efimkina
Department of Radiosurgery, N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, Moscow
Author for correspondence.
Email: yulia@yandex.ru
Russian Federation
I. A. Gladilina
Department of Radiosurgery, N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, MoscowRussian Federation
M. I. Nechushkin
Department of Radiosurgery, N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, MoscowRussian Federation
O. V. Kozlov
Department of Radiosurgery, N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, MoscowRussian Federation
References
Supplementary files

